iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
₹2,665
(1.37%)
Nov 20, 2026|03:58:51 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,920₹0.4 0%5000%
--1,960₹0.05 0%2500%
--2,000₹0.1 -50%14,5000%
--2,040₹0.1 -75%1,250-54.54%
--2,060₹0.45 0%3,7500%
--2,080₹0.1 -93.54%2500%
--2,100₹0.25 -54.54%10,000-4.76%
00%₹440 0%2,120₹0.2 0%2500%
--2,140₹0.3 -82.35%2,0000%
--2,160₹0.25 -16.66%3,7500%
5000%₹123.1 0%2,180₹0.2 -88.57%3,00050%
2,250-25%₹451.5 65.74%2,200₹0.25 -28.57%1,18,0000%
--2,220₹0.15 -50%4,5000%
3,0000%₹400.7 0%2,240₹0.15 -90.32%3,750-11.76%
10,0000%₹363.65 0%2,260₹0.15 -85%24,5001.03%
11,7500%₹347.9 0%2,280₹0.25 -50%6,000-17.24%
55,0000%₹333 0%2,300₹0.1 -50%1,59,0000.15%
2,5000%₹302 0%2,320₹0.3 0%1,750-30%
21,7500%₹299.65 2.84%2,340₹0.35 16.66%10,000-4.76%
5000%₹186 0%2,360₹0.1 -50%8,000-5.88%
00%₹174 0%2,380₹0.35 0%4,7500%
46,000-1.60%₹250 14.67%2,400₹0.65 8.33%74,250-16.57%
4,5000%₹272 0%2,420₹0.65 30%8,750-65%
5,7500%₹195 0%2,440₹0.6 -14.28%86,500-0.28%
11,250-2.17%₹190.9 9.52%2,460₹0.75 7.14%24,75019.27%
30,250-3.2%₹163.8 14.42%2,480₹1.6 -11.11%33,250-5%
45,000-10%₹141.4 4.5%2,500₹2.25 18.42%65,750-26.12%
22,000-4.34%₹122.5 12.02%2,520₹1.9 -29.62%33,250-3.62%
53,500-10.08%₹109.4 27.06%2,540₹2.5 -30.55%28,000-46.91%
19,000-17.39%₹90 25%2,560₹2 -59.18%16,500-17.5%
30,000-25%₹80.7 96.11%2,580₹2.7 -63.01%16,250-15.58%
43,250-34.46%₹58 26.49%2,600₹4.2 -63.63%24,500-33.33%
12,750-16.39%₹40.4 23.54%2,620₹6.35 -65.67%20,500-35.93%
24,000-76.58%₹24.55 5.36%2,640₹14.35 -49.73%29,0004.50%
58,750-28.13%₹16 2.56%2,660₹24 -41.74%35,750-21.85%
77,2503.69%₹7.9 -21.39%2,680₹37 -34.68%31,500-11.88%
2,74,750-21.61%₹7.3 -7%2,700₹61 -16.72%66,750-11.88%
35,25028.18%₹6.25 17.92%2,720₹81.05 -11.42%2,7500%
49,750-6.13%₹6.2 77.14%2,740--
87,250-2.78%₹0.95 -58.69%2,760₹121.75 -20.16%4,0000%
13,0001.96%₹2.75 41.02%2,780₹133.3 1.25%2,500-44.44%
1,28,750-33.46%₹2.65 51.42%2,800₹168.95 0%2,2500%
8,250-15.38%₹2 233.33%2,820--
40,000-0.62%₹0.5 -64.28%2,840--
1,50020%₹1.35 170%2,860--
36,000-14.28%₹1.2 100%2,880₹220 0%2500%
26,250-3.66%₹0.1 -71.42%2,920₹280.2 0%7500%
11,750-17.54%₹0.2 -50%2,960--
15,500-3.12%₹0.2 100%3,000--

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.